Imagion Biosystems Limited (IBX.AX)

AUD 0.02

(5.56%)

Operating Income Summary of Imagion Biosystems Limited

Imagion Biosystems Limited's latest annual operating income in 2023 was -15.81 Million AUD , down -59.45% from previous year.
Imagion Biosystems Limited's latest quarterly operating income in 2024 Q2 was -435.58 Thousand AUD , down 0.0% from previous quarter.
Imagion Biosystems Limited reported an annual operating income of -9.8 Million AUD in 2022, down -62.87% from previous year.
Imagion Biosystems Limited reported an annual operating income of -6.02 Million AUD in 2021, down -12.37% from previous year.
Imagion Biosystems Limited reported a quarterly operating income of -435.58 Thousand AUD for 2024 Q1, up 94.59% from previous quarter.
Imagion Biosystems Limited reported a quarterly operating income of -7.22 Million AUD for 2023 Q2, down -100.0% from previous quarter.

Annual Operating Income Chart of Imagion Biosystems Limited (2023 - 2014)

Historical Annual Operating Income of Imagion Biosystems Limited (2023 - 2014)

Year	Operating Income	Operating Income Growth
2023	-15.81 Million AUD	-59.45%
2022	-9.8 Million AUD	-62.87%
2021	-6.02 Million AUD	-12.37%
2020	-5.35 Million AUD	-56.5%
2019	-3.42 Million AUD	58.91%
2018	-8.33 Million AUD	-21.47%
2017	-6.85 Million AUD	-1110.68%
2016	-566.57 Thousand AUD	86.26%
2015	-4.12 Million AUD	-77.84%
2014	-2.31 Million AUD	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	-435.58 Thousand AUD	0.0%
2024 Q1	-435.58 Thousand AUD	94.59%
2023 Q2	-7.22 Million AUD	-100.0%
2023 Q4	-8.05 Million AUD	-256.36%
2023 FY	-15.63 Million AUD	-59.45%
2023 Q1	-3.61 Million AUD	44.05%
2023 Q3	-2.26 Million AUD	68.72%
2022 Q3	-1.97 Million AUD	65.13%
2022 Q2	-5.67 Million AUD	-100.0%
2022 FY	-9.8 Million AUD	-62.87%
2022 Q1	-2.83 Million AUD	37.92%
2022 Q4	-6.45 Million AUD	-226.4%
2021 Q2	-4.05 Million AUD	-461.51%
2021 FY	-6.02 Million AUD	-12.37%
2021 Q4	-4.56 Million AUD	-100.0%
2021 Q1	-722.56 Thousand AUD	80.07%
2021 Q3	-2.28 Million AUD	43.68%
2020 Q1	-846.81 Thousand AUD	65.38%
2020 FY	-5.35 Million AUD	-56.5%
2020 Q4	-3.62 Million AUD	-103.38%
2020 Q3	-1.78 Million AUD	54.69%
2020 Q2	-3.93 Million AUD	-364.57%
2019 FY	-3.42 Million AUD	58.91%
2019 Q4	-2.44 Million AUD	-67.6%
2019 Q3	-1.45 Million AUD	52.06%
2019 Q2	-3.04 Million AUD	-1190.14%
2019 Q1	-235.94 Thousand AUD	91.17%
2018 Q1	-1.71 Million AUD	31.27%
2018 FY	-8.33 Million AUD	-21.47%
2018 Q4	-2.67 Million AUD	0.0%
2018 Q3	-2.67 Million AUD	-55.64%
2018 Q2	-1.71 Million AUD	0.0%
2017 Q3	-2.49 Million AUD	-168.13%
2017 FY	-6.85 Million AUD	-1110.68%
2017 Q2	-931.57 Thousand AUD	0.0%
2017 Q1	-931.57 Thousand AUD	45.68%
2017 Q4	-2.49 Million AUD	0.0%
2016 Q4	-1.71 Million AUD	0.0%
2016 Q1	- AUD	0.0%
2016 FY	-566.57 Thousand AUD	86.26%
2016 Q2	- AUD	0.0%
2015 Q4	- AUD	0.0%
2015 FY	-4.12 Million AUD	-77.84%
2014 FY	-2.31 Million AUD	0.0%

Peer Operating Income Comparison of Imagion Biosystems Limited

Name	Operating Income	Operating Income Difference
Australian Clinical Labs Limited	56.9 Million AUD	127.791%
BCAL Diagnostics Limited	-5.44 Million AUD	-190.32%
Genetic Signatures Limited	-22.33 Million AUD	29.189%
Genetic Technologies Limited	-6.53 Million AUD	-141.914%
Healius Limited	39.7 Million AUD	139.834%
Integral Diagnostics Limited	5.36 Million AUD	394.658%
INOVIQ Ltd	-9.51 Million AUD	-66.282%
Microba Life Sciences Limited	-26.84 Million AUD	41.086%
Monash IVF Group Limited	-5.34 Million AUD	-195.926%
Rhythm Biosciences Limited	-6.7 Million AUD	-135.779%
Sonic Healthcare Limited	816.45 Million AUD	101.937%